Defining and managing high-risk acute myeloid leukemia (AML) in 2026.

Venclexta (venetoclax) - Roche, AbbVie

http://www.ncbi.nlm.nih.gov/pubmed/42734831

Abdullah Nassir Alqahtani; Fahad Saeed Alshehri; Mariem Ahmad Elsayed; Mohamed Nazem Alibrahim

Sep 15, 2026